KRAS and pancreatic neoplasm: MiR-126 is also the target of other important oncogenes such as KRAS and CRK in pancreatic cancer (69) Therefore, overexpression of miR-126 in SPNs-treated cells can be a reason for inhibition of MIA PaCa-2 proliferation and migration.